Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
48,424,458
-
Shares change
-
-1,618,224
-
Total reported value, excl. options
-
$271,901,414
-
Value change
-
-$14,799,642
-
Put/Call ratio
-
24%
-
Number of buys
-
56
-
Number of sells
-
44
-
Price
-
$5.62
Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q3 2019
As of 30 Sep 2019 TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) had 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 48,424,458 shares of stock of the company.
Largest 10 holders included MILLENNIUM MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, BRIDGER MANAGEMENT, LLC, FMR LLC, Sofinnova Investments, Inc., GEODE CAPITAL MANAGEMENT, LLC, and NORTHERN TRUST CORP.
This table shows 110 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.